Back to company

PHARMPROTECH HOLDING ApS: Financial statements 2022

CVR: 29174644

PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK 5,580,991 compared with DKK 1,278,149 the year before. Equity amounted to DKK 23,589,427. The solvency ratio was 85.4%.

Gross Profit
-10,000 kr.
Profit/Loss
5,580,991 kr.
Equity
23,589,427 kr.
Total Assets
27,631,945 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--10 t.5.6 mio.23.6 mio.-
2021--10 t.1.3 mio.18.1 mio.-
2020--6 t.5.4 mio.16.8 mio.-
2019--44 t.1.9 mio.11.6 mio.-
2018-212 t.2 mio.9.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMPROTECH HOLDING ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PHARMPROTECH HOLDING ApS: The 2021 annual report is outMar 14, 2022

PHARMPROTECH HOLDING ApS has published its annual report for 2021. Gross profit came to DKK -10,000, and the net result was DKK 1,278,149.

About PHARMPROTECH HOLDING ApS

PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity amounted to DKK 38,132,221.